Zolpimist approved for insomnia

(Washington Post) UPDATED 2008-12-23

The U.S. Food and Drug Administration has approved an oral spray for the treatment of insomnia. Zolpimist contains the active ingredient found in the sleep aid Ambien. Though Zolpimist is not a narcotic, there is some small risk of dependency with it as with all sedative hypnotic medications. The FDA has approved the drug in 5mg and 10mg strengths. Read full story >

See all Sleep Disorders News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Zolpimist approved for insomnia

People who read this also read...

What the community is saying...

Heart Day: How Sleep Plays a Role in Congenital Heart Disease

Florence Cardinal